Ensoma
We have a bigger, bolder vision for genomic medicine: treatments as versatile, precise, and far-reaching as the body’s own cells. Our work in cancer and autoimmunity as well as inherited disease is focused on realizing that vision for the millions of people in need.
We have the two key ingredients needed to deliver this vision. First, a phenomenal team inspired to push beyond today’s possible. Second, the breakthrough technology. Engenious™ is the first in vivo editing platform to precisely engineer the immune system with a one-time, off-the-shelf treatment.
AWARDS
451 D Street Unit #711
Boston, MA 02210 US
Boston, MA 02210 US
NEWS
BioSpace is proud to present its NextGen Bio “Class of 2022,” a list of up-and-coming life sciences companies in North America that recently launched.
JOBS
IN THE PRESS